Mereo BioPharma Group (MREO)
NASDAQ: MREO
· Real-Time Price · USD
1.60
-0.04 (-2.44%)
At close: Aug 20, 2025, 10:59 AM
-2.44% (1D)
| Bid | 1.6 |
| Market Cap | 253.75M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -47.19M |
| EPS (ttm) | -0.3 |
| PE Ratio (ttm) | -5.35 |
| Forward PE | -38.25 |
| Analyst | Buy |
| Ask | 1.61 |
| Volume | 636,544 |
| Avg. Volume (20D) | 2,322,253 |
| Open | 1.63 |
| Previous Close | 1.64 |
| Day's Range | 1.60 - 1.65 |
| 52-Week Range | 1.47 - 5.02 |
| Beta | 0.42 |
About MREO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MREO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MREO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Mereo BioPharma Group is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-42.52%
Mereo BioPharma Group shares are trading lower aft...
Unlock content with
Pro Subscription
4 months ago
+1.69%
Mereo BioPharma shares are trading higher after JP Morgan initiated coverage on the stock with an Overweight rating and announced a price target of $7.
